It’s been a little more than 2 months since we pegged the penny stock of OxySure Systems, Inc. (OXYS) to be an easy triple bagger for longs. During that time frame, OXYS stock has done little to disappoint except to trade relatively flat as anticipation builds up for their Q3 filing and even bigger 3 month revenues than they have been putting up all year. Having just launched OxySure Commercial Finance so that their customers can easily lease any one or all of the medical devices and products they produce, the $1.90 price target Sterling Investments Services, Inc. has them pegged for looks like it’s right on target.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
OXYS Stock Quote
Market Cap: 18.26M
Dollar Volume: $2,634
Issued and Outstanding: 24,027,346
14-Day Rel Strength: 49.26%
1st Resistance Point: 0.7798
1st Support Level: 0.72
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
If you looked st the chart for OXYS and then factored in the volume traded daily over the lat 3 months, you would immediately think to yourself that we’ve fallen off of our rocker. To think that a penny stock with a float of around 3 million is trading like this, there must be some obvious reason why other traders aren’t jumping in front of you to grab shares up.
This is the 3rd time since August we have found a reason to discuss why OxySure Systems’ OXYS stock should be a winner for longs. The pioneers of an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use is experiencing their first real year of sales boom and they are likely to be less than that amount of time away from putting up net income numbers in their quarterly/annual reports.
The company’s first 6 months of 2013 as a clear sign that the market for their OxySure Model 615 was virtually untapped. Gross profits from revenues grew by 865%, from $52,916 for the 6 months ended June 30, 2012 to $510,838 for the 6 months ended June 30, 2013. The improvement, hindered only because of an increase in R&D costs and applicable increased costs to sales and marketing still put the company within striking distance of positive cash flow from operations.
Unfortunately, the response from the investment world has yet to put any serious pressure on OXYS stock testing the $1 range. Despite the lack of volume and failure to test such a level, OXYS has had 3 buy ratings issued to it, each with price targets between $1.75 and $2.10 per share making a long-term investor who can sit on a position in perfect position to book a 100% gain or better at some point in 2014.
About OXYS Stock
OxySure Systems, Inc. is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and emergency medical solutions.
Click here to view the SEC filings for OXYS.
Click here to view the website for OxySure.
Last 5 Trading Sessions:
The penny stocks woth going lng on never really seem to have the volume you need to be able to put $10,000 or $20,000 into. However, if approached in the correct manner, a couple grand in OXYS in the 60’s or low 70’s could pay for a 2014 family summer vacation which is better than a kick in the teeth.
Our Next Pick Is Coming Soon!
Text Keyword “AIMHIGH” To 99000 To Make Sure You Don’t Miss It!